2022. However, on March 31, 2023, ALL submitted the form 56-1 One Report for the year 2022 without disclosing information about these disputes. Instead, it stated that “The company has no legal disputes

One Report for the year 2022 without disclosing information about these disputes. Instead, it stated that “The company has no legal disputes that may cause damage to the group’s assets exceeding five

. Sakesan Baisak (5) Mr. Suriyan Thongpikul and (6) Colonel Kanayos Suksanguan failed to provide explanation to questions stated in SEC letter, in which, the SEC exercised the power under Section 58(2) of The

. Sakesan Baisak (5) Mr. Yosapong Pothasuthon and (6) Colonel Kanayos Suksanguan failed to provide explanation to questions stated in SEC letter, in which, the SEC exercised the power under Section 58(2) of

. Sakesan Baisak (5) Mr. Yosapong Pothasuthon and (6) Mr. Suriyan Thongpikul failed to provide explanation to questions stated in SEC letter, in which, the SEC exercised the power under Section 58(2) of The

as he stated. Furthermore, in early August 2021, Dr. Boon still confirmed that the vaccines would be import within August 2021 but later he admitted that such vaccines could not be imported as he

the shareholding proportion of Mr. Khanist that was not current. Accordingly, NEX disclosed information by concealing the facts that should be stated regarding the proportion of NEX's shares held

Mr. Khanist Srivajiraprabha An offence of Nex Point Public Company Limited ("NEX") for disclosing information by concealing material facts that should be stated, in accordance with Section

SEC and publicly disclose the financial statements which have been rectified and audited by the auditor promptly. Earlier, CHUO’s auditor expressed a qualified opinion in the auditor’s report on the

expressed support for the proposed principles and amendments, and some also provided recommendations to enhance this proposal.In drafting the amendments of relevant regulations, the SEC has taken the